Published in Radiat Oncol J on June 30, 2015
An integrated map of genetic variation from 1,092 human genomes. Nature (2012) 59.82
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res (2010) 43.51
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (1994) 36.53
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Identification of the breast cancer susceptibility gene BRCA2. Nature (1996) 17.14
dbNSFP: a lightweight database of human nonsynonymous SNPs and their functional predictions. Hum Mutat (2011) 6.97
Genetic predisposition to breast cancer: past, present, and future. Annu Rev Genomics Hum Genet (2008) 3.40
Disease gene identification strategies for exome sequencing. Eur J Hum Genet (2012) 2.89
Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci U S A (2006) 2.49
SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation. Nature (2010) 2.15
Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996-2004. Breast Cancer Res Treat (2006) 1.43
Identification of single C motif-1/lymphotactin receptor XCR1. J Biol Chem (1998) 1.31
Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer. Breast Cancer Res Treat (2012) 1.15
Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles. PLoS One (2013) 1.10
Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer. Breast Cancer Res Treat (2012) 1.02
Notch signaling as a therapeutic target for breast cancer treatment? Breast Cancer Res (2011) 0.97
XCL1 and XCR1 in the immune system. Microbes Infect (2011) 0.95
The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation. Breast Cancer Res Treat (2008) 0.94
Can unknown predisposition in familial breast cancer be family-specific? Breast J (2013) 0.90
The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study. Fam Cancer (2013) 0.90
BRAF (V600E) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR. Ann Surg Oncol (2012) 0.89
PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations. Breast Cancer Res Treat (2010) 0.84
The role of inflammatory chemokines in lymphoid neoorganogenesis in breast cancer. Biomed Pharmacother (2013) 0.84
Profiling of cell cycle genes of breast cells exposed to etodolac. Oncol Rep (2010) 0.80
Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population. Cancer Genet (2014) 0.78
New technique for developing a proton range compensator with use of a 3-dimensional printer. Int J Radiat Oncol Biol Phys (2013) 0.94
Comparison between in vivo dosimetry and barium contrast technique for prediction of rectal complications in high-dose-rate intracavitary radiotherapy in cervix cancer patients. Strahlenther Onkol (2003) 0.91
Treatment Results of Major Salivary Gland Cancer by Surgery with or without Postoperative Radiation Therapy. Clin Exp Otorhinolaryngol (2010) 0.87
Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06). Clin Breast Cancer (2015) 0.87
Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer. J Breast Cancer (2013) 0.86
The first private-hospital based proton therapy center in Korea; status of the Proton Therapy Center at Samsung Medical Center. Radiat Oncol J (2015) 0.86
Correlation between tumor volume response to radiotherapy and expression of biological markers in patients with cervical squamous cell carcinoma. J Gynecol Oncol (2009) 0.85
Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes. J Breast Cancer (2016) 0.85
Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or Neck. Cancer Res Treat (2014) 0.85
The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis. Cancer Res Treat (2015) 0.85
Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy. Cancer Res Treat (2015) 0.84
Associations between BRCA Mutations in High-Risk Breast Cancer Patients and Familial Cancers Other than Breast or Ovary. J Breast Cancer (2012) 0.84
Outcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically T2 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06). Cancer Res Treat (2014) 0.83
Unique characteristics and failure patterns of metaplastic breast cancer in contrast to invasive ductal carcinoma: a retrospective multicenter case-control study (KROG 13-07). Clin Breast Cancer (2014) 0.81
Association between BRCA Mutation Status, Pathological Findings, and Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk for the Mutation. J Breast Cancer (2013) 0.80
Clinical outcomes of local excision following preoperative chemoradiotherapy for locally advanced rectal cancer. Cancer Res Treat (2014) 0.80
Dummy run of quality assurance program in a phase 3 randomized trial investigating the role of internal mammary lymph node irradiation in breast cancer patients: Korean Radiation Oncology Group 08-06 study. Int J Radiat Oncol Biol Phys (2015) 0.80
Insufficiency fracture after radiation therapy. Radiat Oncol J (2014) 0.80
Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients. Radiat Oncol J (2013) 0.79
Prognostic factors in breast cancer with extracranial oligometastases and the appropriate role of radiation therapy. Radiat Oncol J (2015) 0.78
Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population. Cancer Genet (2014) 0.78
Prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases. Radiat Oncol J (2014) 0.78
Incorporating Risk Factors to Identify the Indication of Post-Mastectomy Radiotherapy in N1 Breast Cancer Treated With Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23). Cancer Res Treat (2016) 0.78
Aggressive clinical course of extramammary Paget disease after radiotherapy. Radiat Oncol J (2014) 0.78
Limited Supraclavicular Radiation Field in Breast Cancer With ≥ 10 Positive Axillary Lymph Nodes. Clin Breast Cancer (2015) 0.77
Asian Society of Gynecologic Oncology International Workshop 2014. J Gynecol Oncol (2015) 0.77
In vivo verification of regional hyperthermia in the liver. Radiat Oncol J (2014) 0.77
Current status of brachytherapy in Korea: a national survey of radiation oncologists. J Gynecol Oncol (2016) 0.76
Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy. Oncotarget (2016) 0.76
Immunohistochemical detection of p53 expression in patients with preoperative chemoradiation for rectal cancer: association with prognosis. Yonsei Med J (2015) 0.76
Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer. J Cancer Res Clin Oncol (2016) 0.75
Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer. Cancer Res Treat (2016) 0.75
Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer. Radiat Oncol J (2016) 0.75
Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08). J Gynecol Oncol (2016) 0.75
Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma. Cancer Res Treat (2015) 0.75
Treatment outcome of hepatic re-irradiation in patients with hepatocellular carcinoma. Radiat Oncol J (2015) 0.75
Prospective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer. Radiat Oncol J (2016) 0.75
Radiation Therapy Alone in cT1-3N0 Non-small Cell Lung Cancer Patients Who Are Unfit for Surgical Resection or Stereotactic Radiation Therapy: Comparison of Risk-Adaptive Dose Schedules. Cancer Res Treat (2016) 0.75
Definitive treatment of primary vaginal cancer with radiotherapy: multi-institutional retrospective study of the Korean Radiation Oncology Group (KROG 12-09). J Gynecol Oncol (2016) 0.75
Can we omit prophylactic inguinal nodal irradiation in anal cancer patients? Radiat Oncol J (2015) 0.75
Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast. J Breast Cancer (2015) 0.75
Radiation Pneumonitis in Association with Internal Mammary Node Irradiation in Breast Cancer Patients: An Ancillary Result from the KROG 08-06 Study. J Breast Cancer (2016) 0.75
Tumor Volume Reduction Rate during Adaptive Radiation Therapy as a Prognosticator for Nasopharyngeal Cancer. Cancer Res Treat (2015) 0.75
Prognostic implications of tumor volume response and COX-2 expression change during radiotherapy in cervical cancer patients. Radiat Oncol J (2012) 0.75
Immunomodulatory effect of captopril and local irradiation on myeloid-derived suppressor cells. Radiat Oncol J (2016) 0.75
Proportion and clinical outcomes of postoperative radiotherapy omission after breast-conserving surgery in women with breast cancer. J Breast Cancer (2015) 0.75
Performance of Momguard, a new non-invasive prenatal testing protocol developed in Korea. Obstet Gynecol Sci (2015) 0.75
Clinical outcomes in patients treated with radiotherapy after surgery for cervical cancer. Radiat Oncol J (2016) 0.75
Two cases of post-radiation sarcoma after breast cancer treatment. J Breast Cancer (2012) 0.75
Can Anorectal Manometry Findings Predict Subsequent Late Gastrointestinal Radiation Toxicity in Prostate Cancer Patients? Cancer Res Treat (2015) 0.75
Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer. Cancer Res Treat (2015) 0.75
Redefining the Positive Circumferential Resection Margin by Incorporating Preoperative Chemoradiotherapy Treatment Response in Locally Advanced Rectal Cancer, a Multicenter Validation Study. Cancer Res Treat (2017) 0.75
Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea. J Breast Cancer (2017) 0.75
The prognostic impact of supraclavicular lymph node in N3-IIIB stage non-small cell lung cancer patients treated with definitive concurrent chemo-radiotherapy. Oncotarget (2017) 0.75
Effect of leukocyte alteration on treatment outcomes following preoperative chemoradiotherapy in patients with rectal cancer. Radiat Oncol J (2017) 0.75
Interobserver variation in target volume for salvage radiotherapy in recurrent prostate cancer patients after radical prostatectomy using CT versus combined CT and MRI: a multicenter study (KROG 13-11). Radiat Oncol J (2017) 0.75
Prognostic Modeling in Pathologic N1 Breast Cancer Without Elective Nodal Irradiation After Current Standard Systemic Management. Clin Breast Cancer (2015) 0.75
Current status and trend of the publication to the SCI and SCIE journals in the field of radiation oncology in Korea for 30 years. Radiat Oncol J (2012) 0.75
The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04). Cancer Res Treat (2017) 0.75
Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline plus Taxane-based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study. Cancer Res Treat (2017) 0.75
Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments. Clin Breast Cancer (2015) 0.75